Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15202598Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#11,007
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Bryce Beverlin Ii as a PI. Multi-PI records show the full award amount for context.
- 5R44CA277898-02R44Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation$874.5Kaward amount
- 1R43DA060713-01R43A novel inhaled dry powder psychoplastogenic formulation for treating persons with opioid use disorder$404.9Kaward amount
Award organization
Organizations that administered FY2024 awards listing Bryce Beverlin Ii as a PI.
FY2024 award administered by Quench Medical, Inc. (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardQuench Medical, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding